Chewy’s Conservative Guidance Appropriate Amid Macro Economic Volatility, Analyst Says

Needham analyst Anna Andreeva reiterated a Buy rating on the shares of Chewy Inc (NYSE:CHWY) with a price target of $55. The…
  • Needham analyst Anna Andreeva reiterated a Buy rating on the shares of Chewy Inc (NYSE:CHWY) with a price target of $55.
  • The analyst said Chewy’s Q3 Net Sales Per Active Customer (NSPAC) maintained mid-teens run-rate as the company added new product categories and expands its catalog with the oldest cohort spending $1,000/year versus Year 1 cohorts at $100-$200/year.
  • Pricing and units contributed equally to growth in 3Q22, the analyst reported.
  • Management expects one round of incremental cost increases in 1Q23 and for both units and price to contribute to sales.
  • The analyst noted net ads were positive first time this year as gross ads accelerated 6% q/q and grew 9% y/y, which coincided with a slight downtick in churn.
  • Advertising expenses increased 18% y/y, and 5% – 7% range is still the right level for FY23.
  • 4Q22 gross margin is expected lower than 3Q22, which the analyst views as conservative given that the industry is still considered rational and compares easing substantially.
  • The analyst cited that Chewy has plenty of initiatives to drive sales and margins between automated FC’s, supply chain/logistics, sponsored ads, insurance and new private label brand.
  • The pet space, the analyst said, is defensive and demand is inelastic plus the headwinds from last year across the supply chain and wage/ labor pressures are dissipating, with sell-side estimates poised for upside.
  • The analyst raises the ’22 and ’23 estimates and expects more positive estimate revisions to drive the stock higher.
  • Price Action: CHWY shares are trading higher by 6.51% at $44.70 on the last check Friday.
  • Photo Via Company
Total
0
Shares
Related Posts
Read More

Reported Late Tuesday April 11, Connect Biopharma Reports FY22 Financial Results And Provides Business Update; FY22 EPS $(2.10); Cash, Cash Equivalents, And Short-Term And Long-Term Investments Were $161.9M As Of December 31, 2022

2022 Financial Results Cash, cash equivalents, and short-term and long-term investments were RMB 1,127.3 million (USD 161.9 million) as of December 31, 2022, compared with RMB 1,706.9 million (USD 267.7 million) at

CNTB